maco har log P y: r O Guhl and Jain, Cardiovasc Pharm Open Access 2017, la 6:5 u p c e n s a A D I:10.4172/2329-6607.1000218 O v c o c i e d r s a s Open Access C Cardiovascular Pharmacology: ISSN: 2329-6607 Review Article Open Access Antiarrhythmic Medications for Cardioversion and Maintenance of Sinus Rhythm in Patients with Cardiac Arrhythmias: A Review of the Literature Guhl EN and Jain SK* Center for Atrial Fibrillation, Heart and Vascular Institute, University of Pittsburgh Medical Center, USA *Corresponding author: Sandeep K Jain, Center for Atrial Fibrillation, Heart and Vascular Institute, University of Pittsburgh School of Medicine, 200 Lothrop St. PUH B535, Pittsburgh, PA 15213, USA, Tel: 412-647-6272; Fax: 412-647-7979; E-mail:
[email protected] Received date: August 12, 2017; Accepted date: September 07, 2017; Published date: September 14, 2017 Copyright: © 2017 Guhl EN, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Introduction: Cardiac arrhythmias, including supraventricular and ventricular tachycardias, portend a higher risk of morbidity and mortality. These arrhythmias also are associated with increased healthcare resource utilization, decreased quality of life, and increased activity impairment. Pharmacologic conversion is a treatment option for conversion to sinus rhythm that has the advantage of avoiding sedation from DC cardioversion. Objective: To review the efficacy, side effects, clearance, and prescribing considerations for antiarrhythmic medications for pharmacologic cardioversion.